$CME

CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?

CME Group (CME) and Morningstar (MORN) are compared as financial infrastructure stocks. CME reported $6.5B revenue, $4B net income, and a 62% net margin in 2025. Morningstar reported $2.4B revenue, $374.2M net income, and a 15.3% net margin. Both face competitive and operational risks.

Original reporting
Published Sep 16, 2026, 1:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 2:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026? — source image
Decision brief

The 30-second read

$CMENeutralLow
01

Why it matters

The article offers no new information beyond what was already disclosed in the companies' annual reports, limiting trading relevance.

02

Market read

A recap of existing financial data; low immediate trading relevance.

03

What to watch

Potential future regulatory changes for CME and AI‑risk for Morningstar are mentioned but not quantified.

Relevance 4/10Novelty 2/10

Background

The piece is a comparative analysis of CME Group and Morningstar using their FY2025 financial results and valuation metrics.

Company-level read

Ticker impact

$CMENeutralHigh confidence
Context

Article recaps CME Group's FY2025 revenue, net income and free cash flow figures from its annual report.

Expected impact

Limited impact; price likely unchanged.

Evidence & confidence

Numbers are already public; article provides no fresh information.

$MORNNeutralHigh confidence
Context

Article summarizes Morningstar's FY2025 revenue, net income and free cash flow from its annual filing.

Expected impact

Limited impact; price likely unchanged.

Evidence & confidence

Data were disclosed earlier; article adds no new insight.

Market effects

Provides a side‑by‑side view of financial‑services infrastructure firms, but no new sector shift.

U.S. financial‑services sector only; no broader regional effect.

Limited; comparison of two U.S. listed companies.

Counterpoint

Without fresh data, any trade based on this comparison is speculative.

Key entities

  • CME Group

    Global derivatives exchange operator.

  • Morningstar

    Investment research and data provider.

Related articles

$CMELow

How New Loan Futures At CME Group (CME) Has Changed Its Investment Story

CME Group launched new S&P UBS USD Liquid Leveraged Loan Index futures on September 14, alongside strong activity in 24/7 gold and silver contracts. The company aims to widen hedging tools and attract more users. CME Group's revenue is projected to reach US$8.0b by 2029, with a 5.6% yearly growth rate. The launch of CME Securities Clearing in U.S. Treasuries is another key development.

$IBKRMedAI 8/10

Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike

The Federal Reserve raised rates by 25 bps on Sept. 16, reversing earlier expectations. Brokers and exchanges like Interactive Brokers (IBKR), Robinhood (HOOD), and CME Group (CME) may benefit from rate hikes. IBKR could see a 2% lift in net interest income (NII) per 25 bps hike, while HOOD's outlook depends on trading volume, and CME benefits from rate path uncertainty.

$CMEMed

CME to List GPU Rental Futures on October 5: H100, B200

CME Group plans to list futures tied to Nvidia GPU rental prices (H100, B200) on October 5, subject to regulatory review. Contracts represent 730 GPU-hours, financially settled, and based on Silicon Data's rental indices. Futures aim to help AI developers and cloud providers hedge rental costs. CME and Silicon Data provide trading and benchmark data, respectively.

$CMEMed

CME Group Launches S&P UBS USD Liquid Leveraged Loan Index Futures

CME Group launched S&P UBS USD Liquid Leveraged Loan Index futures on September 14, offering a new tool for trading leveraged loan exposures. The futures track the S&P UBS index and provide capital-efficient, centrally cleared contracts. Over 1.5 million contracts have traded since June 2024, with open interest exceeding $2 billion in September 2026. The contracts are available on CME Globex and CME ClearPort.

$MORNMed

Why Morningstar (MORN) Stock Is Trading Up Today

Morningstar (MORN) shares rose 4.5% to $199.61 after OpenAI integrated PitchBook's data into ChatGPT for Financial Services. The platform uses GPT-6 Astra for financial modeling and report creation, enhancing workflows for analysts. Investors view this as a validation of PitchBook's data and a potential licensing opportunity. Morningstar's stock is volatile, down 5.1% YTD and 19.8% from its 52-week high.